The MPZ Gene DI-CMTD Genetic Test is a specialized diagnostic tool designed to identify mutations in the MPZ gene, which are associated with a subtype of Charcot-Marie-Tooth disease known as Dominant Intermediate Charcot-Marie-Tooth Disease Type D (DI-CMTD). Charcot-Marie-Tooth disease is a group of inherited disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems, primarily in the feet and legs, and sometimes the hands and arms.

The MPZ gene plays a crucial role in the functioning and maintenance of the myelin sheath, a protective layer that surrounds nerve fibers. Mutations in this gene can disrupt the normal function of peripheral nerves, leading to the symptoms observed in DI-CMTD. Early and accurate diagnosis through the MPZ Gene DI-CMTD Genetic Test can be critical for the management and treatment of the condition, allowing for targeted therapies and interventions that can improve quality of life.

This genetic test is offered by DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The test is priced at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed to ensure accurate results. For individuals displaying symptoms of Charcot-Marie-Tooth disease or those with a family history of the condition, the MPZ Gene DI-CMTD Genetic Test can provide essential insights into their genetic makeup, guiding both patients and healthcare providers in making informed decisions about management and treatment strategies.